earnings
confidence high
sentiment positive
materiality 0.75
Biote reports record FY2022 revenue $165M, Q4 adj EBITDA up 40%; guides FY2023 rev $190-200M
biote Corp.
- Q4 revenue $44.5M (+18.5%), net income $12.8M, diluted EPS $0.18; adjusted EBITDA $13.1M (+40%).
- FY2022 revenue $165.0M (+18.3%), net income $1.3M, diluted EPS loss ($0.12); adjusted EBITDA $50.1M (+24.6%).
- 2023 guidance: revenue $190-200M, adjusted EBITDA $56-60M; expects stronger H2 performance.
- Completed secondary offering in Jan 2023 to increase trading liquidity and broaden institutional ownership.